PRMT1 and hepatocellular carcinoma: FBXO7 expression is diminished in human HCC tissue, and its expression level exhibits a negative correlation with the methylation levels of PRMT1 and PHGDH, presenting novel molecular pathways and possible therapeutic targets for cancer treatment [147].